Products

Scribly.io

Low-cost content marketing services to fuel your business 🚀

scribly.io Marketing / AI SEO Content

AI Benchmark
Monthly visits
<5K
Oct 2026
MRR
$30KClaimed
Disclosed 2026-09-29Indie Hackers
Entry price
Unknown
No monthly subscription pricing
Creators
Daniella Mancini
No social account linked+1 more creators
Launched
8y ago
2018-04-27 · Est.

Traffic & revenue

Monthly visitsData through Oct 2026
MRRSelf-reported, unverified · Indie Hackers
  • Sep 2026$30KSelf-reported MRR · unverified
Events1 revenue disclosure

Revenue evidence

Publicly disclosed & verified revenue figures, sorted by date

Marketing moves

Launches, search & content, referrals, promotions
  • New product launchLaunch

    Apr 27, 2018 · 8y agoWebsite

Traffic sources

Oct 2026

Traffic breakdown

Channels

No data yet

Countries

No data yet

Search

Domain authority —Domain registered 2018-04-27

No search keyword data for this website yet.

Traffic data: Vaneform

Pricing

Public pricing: Contact salesRaw source text; structured plans are extracted after website capture.

Pages & changes

Tracked since 2026-08-10

Key pages

Weekly snapshots

No page snapshots yet. Once followed, home and pricing pages are captured weekly.

Changes

No pricing, plan, or positioning changes detected since tracking started.

Questions & evidence

How much website traffic does Scribly.io get?
Vaneform estimates <5K website visits in 2026-10. Visits can include repeat visits; this estimate measures web traffic separately from paying customers or revenue.Source
What is Scribly.io and what platforms does it support?
Scribly.io is catalogued under AI SEO Content: Low-cost content marketing services to fuel your business 🚀. Supported platforms: Web.
What is Scribly.io's publicly disclosed revenue?
Indie Hackers records a founder-reported figure of $30K /mo stated on 2026-09-29.Source

Related products in this category

Marketing / AI SEO Content

These products share a catalog category. Compare customer tasks, features and deployment requirements before treating them as alternatives.